Laguna Niguel, CA, United States of America

Peter C Baciu

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Rowley, MA (US) (2004)
  • Laguna Niguel, CA (US) (2003 - 2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Peter C Baciu

Introduction

Peter C Baciu is a notable inventor based in Laguna Niguel, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to the complement pathway. With a total of five patents to his name, Baciu's work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Among his latest patents are innovations related to complement component C5 antibodies. These patents disclose antibodies and polynucleotides that can be utilized to prevent, control, or reduce the activity of the complement pathway. The disclosures also include compositions and methods for diagnosing and treating diseases that are mediated by or involve complement C5. Specifically, these patents focus on C5 antibodies, which are crucial for advancing therapeutic strategies.

Career Highlights

Throughout his career, Peter C Baciu has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Allergan, Inc. and Xencor, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in his field.

Collaborations

Baciu has collaborated with several professionals in his field, including Yanbin Liang and Jason Guu. These collaborations have likely enriched his work and fostered innovation in the projects he has undertaken.

Conclusion

Peter C Baciu's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on complement component C5 antibodies is paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…